Modeling and Simulation Move Downstream

This article explores two commercial platforms, and touches on a new program underway in the UK.

Today, some of the most advanced computer-based models are being used for early research. However, the move to continuous processing has stimulated interest in process optimization and control. This article explores two commercial platforms, and touches on a new program underway in the UK.

Read this article

from Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.

View other articles in the

2016 Solid Dosage Drug Development and Manufacturing eBook.

Articles in this issue

over 9 years ago

Article

Meeting USP Guidelines for Elemental Impurity Analysis with X-ray Fluorescence Spectrometry

over 9 years ago

Article

Optimizing Tablet Compression

over 9 years ago

Article

Excipient Quality and Selection

over 9 years ago

Article

Filling the Analysis Gap in the Move to Continuous Processing

over 9 years ago

Article

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances

over 9 years ago

Article

Unifying Excipient Databases

over 9 years ago

Article

Establishing a New Performance Standard for HPMC Capsules

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!